Europace, 1099-5129

Journal

  1. 2020
  2. Himmelreich, J. C. L., Veelers, L., Lucassen, W. A. M., Schnabel, R. B., Rienstra, M., van Weert, H. C. P. M., & Harskamp, R. E. (2020). Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis. Europace. https://doi.org/10.1093/europace/euaa005
  3. ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term Registry investigators, Grecu, M., Blomström-Lundqvist, C., Kautzner, J., Laroche, C., Van Gelder, I. C., ... Arbelo, E. (2020). In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registry: sex differences. Europace, 22(1), 66-73. https://doi.org/10.1093/europace/euz225
  4. 2019
  5. ESC Scientific Document Group , Goette, A., Auricchio, A., Boriani, G., Braunschweig, F., Terradellas, J. B., ... Heidbüchel, H. (2019). EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. Europace, 21(7), 993-994. https://doi.org/10.1093/europace/euz055
  6. van der Wall, S. J., van Rein, N., van den Bemt, B., Kruip, M. J. H. A., Meijer, K., te Boome, L. C. J., ... Huisman, M. (2019). Performance of idarucizumab as antidote of dabigatran in daily clinical practice. Europace, 21(3), 414-420. https://doi.org/10.1093/europace/euy220
  7. 2018
  8. Engels, E. B., Mafi-Rad, M., Hermans, B. J. M., Aranda, A., van Stipdonk, A. M. W., Rienstra, M., ... Vernooy, K. (2018). Tailoring device settings in cardiac resynchronization therapy using electrograms from pacing electrodes. Europace, 20(7), 1146-1153. https://doi.org/10.1093/europace/eux208
  9. Kotecha, D., Breithardt, G., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., ... Kirchhof, P. (2018). Integrating new approaches to atrial fibrillation management: The 6th AFNET/EHRA Consensus Conference. Europace, 20(3), 395-407. https://doi.org/10.1093/europace/eux318
  10. Koyak, Z., de Groot, J. R., Krimly, A., Mackay, T. M., Bouma, B. J., Silversides, C. K., ... Harris, L. (2018). Cardiac resynchronization therapy in adults with congenital heart disease. Europace, 20(2), 315-322. https://doi.org/10.1093/europace/euw386
  11. 2017
  12. Koyak, Z., de Groot, J. R., Bouma, B. J., Zwinderman, A. H., Silversides, C. K., Oechslin, E. N., ... Harris, L. (2017). Sudden cardiac death in adult congenital heart disease: Can the unpredictable be foreseen? Europace, 19(3), 401-406. https://doi.org/10.1093/europace/euw060
  13. 2016
  14. Kaasenbrood, F., Hollander, M., Rutten, F. H., Gerhards, L. J., Hoes, A. W., & Tieleman, R. G. (2016). Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace, 18(10), 1514-1520. https://doi.org/10.1093/europace/euv426
  15. Korenstra, J., Wijtvliet, E. P. J., Veeger, N. J. G. M., Geluk, C. A., Bartels, G. L., Posma, J. L., ... Tieleman, R. G. (2016). Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation. Europace, 18(9), 1319-1327. https://doi.org/10.1093/europace/euv397
  16. 2015
  17. 2014
  18. 2013
Previous 1 2 Next

ID: 1533233